LAB STANDARD BIOTOOLS INC.
Nasdaq · SEC CIK 1162194 · EDGAR
- Bought, last 12 months
- $14.41M 5 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 174 since 2021-08-24, latest 2026-08-24 17:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| Casdin Eli | Dir, 10% | $1.37M | — |
| Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| Kim Hanjoon Alex | CFO | — | — |
| Mackay Sean | SVP, Chief Business Off | — | — |
| Cox Troy | Dir | — | — |
| Carey Thomas D. | Dir | — | — |
| Egholm Michael | Pres, CEO, Dir | — | — |
| Witney Frank | Dir | — | — |
Transactions 201
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 17:06 | 2026-08-20 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $0.672 | -25.7K | 1.48M | -2% | -$17.3K | |
| 2026-08-24 17:05 | 2026-08-20 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $0.672 | -28.2K | 2.53M | -1% | -$18.9K | |
| 2026-08-24 17:04 | 2026-08-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $0.672 | -97.6K | 6.14M | -2% | -$65.6K | |
| 2026-08-04 18:01 | 2026-08-03 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $0.868 | -362.6K | 6.24M | -5% | -$314.8K | |
| 2026-07-27 19:28 | 2026-07-23 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $0.895 | -202.5K | 2.56M | -7% | -$181.2K | |
| D | 2026-06-23 17:45 | 2026-06-18 | LAB | Carey Thomas D. | Dir | A - Grant | $0.00 | +99.1K | 344.5K | +40% | $0 |
| 2026-06-23 17:45 | 2026-06-20 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +500.0K | 1.51M | +50% | $0 | |
| D | 2026-06-23 17:43 | 2026-06-18 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +99.1K | 310.0K | +47% | $0 |
| D | 2026-06-23 17:41 | 2026-06-18 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +99.1K | 3.05M | +3% | $0 |
| D | 2026-06-23 17:41 | 2026-06-18 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +99.1K | 475.7K | +26% | $0 |
| D | 2026-06-23 17:39 | 2026-06-18 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +99.1K | 335.3K | +42% | $0 |
| D | 2026-06-23 17:39 | 2026-06-18 | LAB | HIBBS KATHY L | Dir | A - Grant | $0.00 | +99.1K | 236.8K | +72% | $0 |
| 2026-05-22 17:20 | 2026-05-20 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.00 | -18.9K | 2.76M | -0.7% | -$18.9K | |
| 2026-05-22 17:17 | 2026-05-20 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $1.00 | -25.7K | 1.01M | -2% | -$25.7K | |
| 2026-05-22 17:17 | 2026-05-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.00 | -97.6K | 6.60M | -1% | -$97.6K | |
| D | 2026-04-08 21:55 | 2026-03-20 | LAB | Egholm Michael | Pres, CEO, Dir | A - Grant | $0.00 | +1.04M | 6.59M | +19% | $0 |
| D | 2026-04-08 21:55 | 2026-04-06 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +196.5K | 6.79M | +3% | $0 |
| D | 2026-04-08 21:55 | 2026-04-06 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $0.908 | -95.0K | 6.70M | -1% | -$86.3K |
| D | 2026-04-08 21:55 | 2026-03-20 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +272.1K | 1.03M | +36% | $0 |
| D | 2026-04-08 21:55 | 2026-03-20 | LAB | Kim Hanjoon Alex | CFO | A - Grant | $0.00 | +323.2K | 2.73M | +13% | $0 |
| D | 2026-04-08 21:55 | 2026-04-06 | LAB | Kim Hanjoon Alex | CFO | M - OptEx | $0.00 | +70.2K | 2.80M | +3% | $0 |
| D | 2026-04-08 21:55 | 2026-04-06 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $0.908 | -21.3K | 2.78M | -0.8% | -$19.3K |
| 2026-03-02 | 2026-02-26 | LAB | Carey Thomas D. | Dir | A - Grant | $1.17 | +51.3K | 245.3K | +26% | +$60.0K | |
| 2026-03-02 | 2026-02-26 | LAB | Casdin Eli | Dir, 10% | A - Grant | $1.17 | +53.0K | 2.95M | +2% | +$62.0K | |
| 2026-03-02 | 2026-02-26 | LAB | Cox Troy | Dir | A - Grant | $1.17 | +57.3K | 376.6K | +18% | +$67.0K | |
| 2026-02-24 | 2026-02-23 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.15 | -66.1K | 5.55M | -1% | -$76.0K | |
| 2026-02-24 | 2026-02-23 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $1.15 | -19.7K | 760.2K | -3% | -$22.6K | |
| 2026-02-24 | 2026-02-23 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.15 | -12.7K | 2.41M | -0.5% | -$14.7K | |
| MI | 2025-12-04 | 2025-12-02+ | LAB | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | P - Purchase | $1.44 | +350.0K | 72.10M | +0.5% | +$503.0K |
| MI | 2025-11-26 | 2025-11-24+ | LAB | Casdin Partners GP, LLC | Dir, 10% | P - Purchase | $1.30 | +7.70M | 64.20M | +14% | +$10.03M |
| 2025-11-24 | 2025-11-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.28 | -63.5K | 5.62M | -1% | -$81.3K | |
| 2025-11-24 | 2025-11-20 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $1.28 | -19.7K | 779.8K | -2% | -$25.2K | |
| 2025-11-24 | 2025-11-20 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.28 | -12.7K | 2.42M | -0.5% | -$16.3K | |
| MI | 2025-11-20 | 2025-11-18+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $1.28 | +1.07M | 63.60M | +2% | +$1.37M |
| MI | 2025-11-17 | 2025-11-13+ | LAB | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.22 | +925.0K | 62.75M | +1% | +$1.12M |
| MI | 2025-11-12 | 2025-11-07+ | LAB | Casdin Partners GP, LLC | Dir, 10% | P - Purchase | $1.17 | +1.18M | 61.38M | +2% | +$1.38M |
| I | 2025-09-11 | 2025-09-09 | LAB | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.29 | +100.0K | 60.88M | +0.2% | +$129.0K |
| MI | 2025-09-05 | 2025-09-03+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $1.27 | +500.0K | 60.52M | +0.8% | +$637.5K |
| MI | 2025-08-26 | 2025-08-22+ | LAB | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.25 | +525.0K | 60.27M | +0.9% | +$657.5K |
| 2025-08-22 | 2025-08-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.27 | -54.9K | 5.68M | -1.0% | -$69.7K | |
| 2025-08-22 | 2025-08-20 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.27 | -12.7K | 2.43M | -0.5% | -$16.2K | |
| 2025-08-22 | 2025-08-20 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $1.27 | -19.7K | 799.5K | -2% | -$25.0K | |
| MI | 2025-08-15 | 2025-08-13+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $1.24 | +358.2K | 59.75M | +0.6% | +$442.4K |
| 2025-08-05 | 2025-08-01 | LAB | Egholm Michael | Pres, CEO, Dir | A - Grant | $0.00 | +3.00M | 5.74M | +110% | $0 | |
| 2025-08-05 | 2025-08-01 | LAB | Kim Hanjoon Alex | CFO | A - Grant | $0.00 | +1.50M | 2.44M | +159% | $0 | |
| D | 2025-06-24 | 2025-06-20 | LAB | Carey Thomas D. | Dir | A - Grant | $0.00 | +94.6K | 194.1K | +95% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | HIBBS KATHY L | Dir | A - Grant | $0.00 | +94.6K | 137.7K | +219% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +94.6K | 256.4K | +58% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +94.6K | 2.90M | +3% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +94.6K | 210.9K | +81% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +94.6K | 236.2K | +67% | $0 |
| 2025-05-30 | 2025-05-28 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.09 | -9,906 | 2.73M | -0.4% | -$10.8K | |
| 2025-05-30 | 2025-05-28 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.09 | -2,583 | 927.7K | -0.3% | -$2,815 | |
| 2025-05-30 | 2025-05-28 | LAB | Mackay Sean | SVP, Chief Business Off | F - Tax | $1.09 | -23.9K | 819.2K | -3% | -$26.1K | |
| 2025-05-28 | 2025-05-23 | LAB | Kim Hanjoon Alex | CFO | S - Sale | $0.94 | -1,428 | 930.3K | -0.2% | -$1,342 | |
| 2025-05-28 | 2025-05-23 | LAB | Egholm Michael | Pres, CEO, Dir | S - Sale | $0.94 | -5,473 | 2.74M | -0.2% | -$5,145 | |
| 2025-05-28 | 2025-05-23 | LAB | Mackay Sean | SVP, Chief Business Off | S - Sale | $0.94 | -13.2K | 843.1K | -2% | -$12.4K | |
| 2025-05-27 | 2025-05-22 | LAB | Kim Hanjoon Alex | CFO | S - Sale | $1.00 | -1,355 | 931.7K | -0.1% | -$1,355 | |
| 2025-05-27 | 2025-05-22 | LAB | Egholm Michael | Pres, CEO, Dir | S - Sale | $1.00 | -5,116 | 2.75M | -0.2% | -$5,116 | |
| M | 2025-05-23 | 2025-05-21+ | LAB | Mackay Sean | SVP, Chief Business Off | S - Sale | $1.02 | -25.4K | 868.8K | -3% | -$25.8K |
| 2025-05-22 | 2025-05-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.05 | -18.3K | 2.76M | -0.7% | -$19.3K | |
| 2025-05-22 | 2025-05-21 | LAB | Egholm Michael | Pres, CEO, Dir | S - Sale | $1.03 | -4,719 | 2.75M | -0.2% | -$4,861 | |
| 2025-05-22 | 2025-05-20 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.05 | -6,364 | 934.5K | -0.7% | -$6,682 | |
| 2025-05-22 | 2025-05-21 | LAB | Kim Hanjoon Alex | CFO | S - Sale | $1.03 | -1,407 | 933.1K | -0.2% | -$1,449 | |
| D | 2025-04-08 | 2025-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +196.5K | 2.83M | +7% | $0 |
| D | 2025-04-08 | 2025-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.07 | -57.7K | 2.77M | -2% | -$61.7K |
| D | 2025-04-08 | 2025-04-04 | LAB | Kim Hanjoon Alex | CFO | F - Tax | $1.07 | -21.4K | 940.8K | -2% | -$22.9K |
| D | 2025-04-08 | 2025-04-04 | LAB | Kim Hanjoon Alex | CFO | M - OptEx | $0.00 | +70.2K | 962.3K | +8% | $0 |
| D | 2025-03-24 | 2025-03-21 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +281.7K | 881.7K | +47% | $0 |
| D | 2025-03-24 | 2025-03-21 | LAB | Kim Hanjoon Alex | CFO | A - Grant | $0.00 | +338.3K | 892.1K | +61% | $0 |
| D | 2025-03-24 | 2025-03-21 | LAB | Egholm Michael | Pres, CEO, Dir | A - Grant | $0.00 | +1.19M | 2.64M | +82% | $0 |
| MI | 2025-03-04 | 2025-02-28 | LAB | Casdin Capital, LLC | Dir, 10% | J - Other | $1.07 | 0 | 59.39M | New | $0 |
| I | 2025-03-04 | 2025-02-28 | LAB | Casdin Capital, LLC | Dir, 10% | P - Purchase | $1.07 | +4.82M | 58.85M | +9% | +$5.16M |
| 2025-03-04 | 2025-02-28 | LAB | Casdin Capital, LLC | Dir, 10% | A - Grant | $1.07 | +58.2K | 2.81M | +2% | +$62.3K | |
| 2025-03-04 | 2025-02-28 | LAB | Cox Troy | Dir | A - Grant | $1.07 | +62.9K | 224.7K | +39% | +$67.3K | |
| 2025-03-04 | 2025-02-28 | LAB | Carey Thomas D. | Dir | A - Grant | $1.07 | +56.3K | 99.5K | +131% | +$60.3K | |
| 2025-02-24 | 2025-02-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.39 | -31.0K | 1.45M | -2% | -$43.1K | |
| 2024-11-21 | 2024-11-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.51 | -28.8K | 1.47M | -2% | -$43.5K | |
| 2024-09-05 | 2024-08-20 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.91 | -29.1K | 1.50M | -2% | -$55.6K | |
| 2024-09-05 | 2024-08-20 | LAB | Black Jeffrey G. | SVP, CFO | F - Tax | $1.91 | -6,690 | 421.6K | -2% | -$12.8K | |
| I | 2024-08-29 | 2024-08-27 | LAB | Casdin Private Growth Equity Fund, L.P. | Dir | P - Purchase | $2.19 | +250.0K | 54.03M | +0.5% | +$547.5K |
| MI | 2024-08-26 | 2024-08-22+ | LAB | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | P - Purchase | $2.06 | +750.0K | 53.33M | +1% | +$1.55M |
| MI | 2024-08-21 | 2024-08-19+ | LAB | Casdin Amplify Fund, LP | Dir | P - Purchase | $1.88 | +1.25M | 53.03M | +2% | +$2.35M |
| D | 2024-08-19 | 2024-08-15 | LAB | Black Jeffrey G. | SVP, CFO | F - Tax | $1.55 | -4,695 | 428.3K | -1% | -$7,277 |
| D | 2024-08-19 | 2024-08-15 | LAB | Black Jeffrey G. | SVP, CFO | M - OptEx | $0.00 | +13.2K | 433.0K | +3% | $0 |
| I | 2024-08-16 | 2024-08-14 | LAB | Casdin Private Growth Equity Fund II, L.P. | Dir | P - Purchase | $1.59 | +1.20M | 51.78M | +2% | +$1.91M |
| MI | 2024-08-13 | 2024-08-09+ | LAB | Casdin Amplify Fund, LP | Dir | P - Purchase | $1.62 | +1.58M | 50.58M | +3% | +$2.56M |
| MI | 2024-08-09 | 2024-08-07+ | LAB | Casdin Private Growth Equity Fund, L.P. | Dir | P - Purchase | $1.61 | +1.07M | 49.00M | +2% | +$1.72M |
| MI | 2024-08-06 | 2024-08-02+ | LAB | Casdin Eli | Dir, 10% | P - Purchase | $1.62 | +1.20M | 47.73M | +3% | +$1.95M |
| 2024-07-23 | 2024-07-19 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +1,588 | 2.75M | +0.1% | $0 | |
| D | 2024-07-02 | 2024-06-28 | LAB | Carey Thomas D. | Dir | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | HIBBS KATHY L | Dir | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | Witney Frank | Dir | A - Grant | $0.00 | +43.1K | 116.3K | +59% | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +43.1K | 2.75M | +2% | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | Cox Troy | Dir | A - Grant | $0.00 | +43.1K | 161.8K | +36% | $0 |
| D | 2024-07-02 | 2024-06-28 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +43.1K | 141.6K | +44% | $0 |
| MI | 2024-06-21 | 2024-06-18 | LAB | Casdin Capital, LLC | Dir, 10% | J - Other | $2.05 | 0 | 545.0K | New | $0 |
| I | 2024-05-28 | 2024-05-23 | LAB | Casdin Partners FO1-MSV, LP | Dir | P - Purchase | $2.60 | +100.0K | 46.08M | +0.2% | +$260.0K |
| MI | 2024-05-22 | 2024-05-20+ | LAB | Casdin Partners GP, LLC | Dir, 10% | P - Purchase | $2.57 | +600.0K | 45.83M | +1% | +$1.54M |
| D | 2024-05-21 | 2024-05-20 | LAB | Egholm Michael | Pres, CEO, Dir | A - Grant | $0.00 | +1.00M | 1.53M | +188% | $0 |
Purchase Sale Sale after option exercise All abbreviations